BiotechTube
Home/Pipeline/Trastuzumab Biosimilar

Trastuzumab Biosimilar

HER2‑positive Breast Cancer

Phase 3Active

Key Facts

Indication
HER2‑positive Breast Cancer
Phase
Phase 3
Status
Active
Companies
Hetero, Bio Usawa Biotechnology, Innogene Kalbiotech

About Hetero

India’s top generic and biosimilar drug manufacturer with a global API and antiviral portfolio.

View full company profile

About Bio Usawa Biotechnology

African biotech building low‑cost monoclonal antibody biosimilars to expand cancer treatment access.

View full company profile

About Innogene Kalbiotech

Asian‑focused biotech delivering oncology biologics, biosimilars, and precision diagnostics across ASEAN.

View full company profile

Therapeutic Areas

Infectious DiseasesVirologyAntiretroviralBiosimilarsOncology

Other HER2‑positive Breast Cancer Drugs

DrugCompanyPhase
Herceptin (Trastuzumab) BiosimilarNeuClonePhase 1
Perjeta (Pertuzumab) BiosimilarNeuCloneProcess Scale‑up
MagSense™ HER2 Imaging AgentImagion BiosystemsPhase 2
P-003Panacea BiotecPhase 3
Legrand‑Herceptin BiosimilarLaboratorios LegrandCommercial
AfriMab-1Afrigen BiologicsPreclinical
Biosimilar TrastuzumabBiosidusCommercial
TrazherInnogene KalbiotechCommercial
MINC‑trastuzumabSuntec MedicalPreclinical